Current Efforts for Development of Novel Therapeutics to Combat Antibiotic Resistance

A special issue of Antibiotics (ISSN 2079-6382).

Deadline for manuscript submissions: closed (15 September 2022) | Viewed by 5439

Special Issue Editor


E-Mail Website
Guest Editor
School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
Interests: antimicrobial therapeutics; cationic antimicrobial peptides; drug-resistant bacteria; antibiotics

Special Issue Information

Dear Colleagues,

While most public health efforts have been directed towards the COVID-19 pandemic in the last two years, it is imperative that we continue to address other public health challenges. Among these challenges is the crisis created by antibiotic resistance, which requires a comprehensive multipronged approach. An important consideration is the development of therapeutics with novel mechanisms. It is in this context that we are presenting this Special Issue of Antibiotics to review the progress on novel approaches to antimicrobial therapy and the prospects for new therapeutics for overcoming resistance to traditional antibiotics.

Prof. Dr. Berthony Deslouches
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 630 KiB  
Review
Stability of Antimicrobials in Elastomeric Pumps: A Systematic Review
by Beatriz Fernández-Rubio, Paula del Valle-Moreno, Laura Herrera-Hidalgo, Alicia Gutiérrez-Valencia, Rafael Luque-Márquez, Luis E. López-Cortés, José María Gutiérrez-Urbón, Sonia Luque-Pardos, Aurora Fernández-Polo and María V. Gil-Navarro
Antibiotics 2022, 11(1), 45; https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics11010045 - 30 Dec 2021
Cited by 12 | Viewed by 5050
Abstract
Outpatient parenteral antimicrobial therapy (OPAThttp) programs have become an important healthcare tool around the world. Portable elastomeric infusion pumps are functional devices for ambulatory delivery of antimicrobial drugs, and their stability is an essential point to guarantee an appropriate infusion administration. We conducted [...] Read more.
Outpatient parenteral antimicrobial therapy (OPAThttp) programs have become an important healthcare tool around the world. Portable elastomeric infusion pumps are functional devices for ambulatory delivery of antimicrobial drugs, and their stability is an essential point to guarantee an appropriate infusion administration. We conducted a systematic review to provide a synthesis and a critical evaluation of the current evidence regarding antimicrobial stability in elastomeric pumps. Data sources were PubMed, EMBASE, and Web of Sciences. The review protocol was registered on the Center for Open Science, and it was carried out following the PRISMA guidelines. Studies were eligible if the aim was the evaluation of the physicochemical stability of an antimicrobial agent stored in an elastomeric device. Of the 613 papers identified, 33 met the inclusion criteria. The most studied group of antimicrobials was penicillins, followed by cephalosporins and carbapenems. In general, the stability results of the antimicrobials that have been studied in more than one article agree with each other, with the exception of ampicillin, flucloxacillin, and ceftazidime. The antibiotics that displayed a longer stability were glycopeptides and clindamycin. Regarding the stability of antifungals and antivirals, only caspofungin, voriconazole, and ganciclovir have been investigated. The information provided in this article should be considered in patient treatments within the OPAT setting. Further stability studies are needed to confirm the appropriate use of the antimicrobials included in this program to ensure optimal patient outcomes. Full article
Show Figures

Figure 1

Back to TopTop